Eli Lilly reached a $1-trillion market capitalisation on Friday, becoming the first pharmaceutical company to join the trillion-dollar club dominated by tech giants. It briefly hit the $1-trillion mark in morning trading before retreating. A more than 35% rally in the company's stock this year has largely been driven by the explosive growth of the weight-loss drug market, reports said.